Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

324 Press Releases
DateTitleCompany
09 May 12 Teva Appoints Michael Hayden as President of Global Research and Development and Chief Scientific Officer Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 Apr 12 Teva settles Nuvigil litigation with Mylan Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
26 Apr 12 Preliminary Data Suggest Spasticity May Be Reduced in Relapsing-Remitting Multiple Sclerosis Patients Who Transitioned to Teva’s COPAXONE® Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
20 Apr 12 Teva to Report First Quarter 2012 Financial Results on May 9, 2012 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
18 Apr 12 Teva Announces New Data on Central Nervous System Products to Be Presented at 2012 American Academy of Neurology Annual Meeting Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
05 Apr 12 FDA Decides Teva is Sole First-to-File on Provigil® Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
02 Apr 12 Teva Announces Pricing of EUR 1 Billion and CHF 450 Million of Senior Notes, and the Closing of a New JPY 100 Billion Unsecured Syndicated Facility Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
02 Apr 12 Teva Announces Launch of Generic Avapro® and Generic Avalide® in the United States; Awarded 180-Day Period of Marketing Exclusivity Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 Mar 12 Teva Announces Launch of Authorized Generic of Provigil® Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
28 Mar 12 Teva Announces Launch of Generic Seroquel® in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
26 Mar 12 Teva Announces FDA Approval of QNASLTM (beclomethasone dipropionate), a New Nonaqueous Nasal Aerosol, for the Treatment of Allergic Rhinitis Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
21 Mar 12 Teva Pharmaceutical Industries Ltd. to Transfer Listing to NYSE Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Mar 12 Phase III Study of Teva's Oral Laquinimod Published in the New England Journal of Medicine Demonstrates Clinical Benefits for Multiple Sclerosis Patients Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Mar 12 Teva Announces Launch of Generic Lexapro® in the United States; Awarded 180-Day Period of Marketing Exclusivity Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Mar 12 Teva to Present at the Barclays Capital Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Mar 12 Teva and OncoGenex Announce Updates to Custirsen Development Program in Advanced Prostate Cancer Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Mar 12 QNASLTM Phase III Data Indicate Investigational Therapy with New Mode of Delivery has Positive Safety and Effective Profile in Treatment of Seasonal and Perennial Allergic Rhinitis Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Mar 12 Teva Announces Launch of Generic Prometrium® Capsules in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Mar 12 Teva to Present at the 2012 RBC Capital Markets’ Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Mar 12 Teva to Present at the Citi 2012 Global Health Care Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Feb 12 Teva Reports Fourth Quarter and Full Year 2011 Results Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
17 Jan 12 Teva to Report Fourth Quarter and Full Year 2011 Financial Results on February 15, 2012 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
09 Jan 12 Teva to Present at the 30th Annual J.P. Morgan Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
03 Jan 12 Advanced Magnetic Resonance Imaging Technology Suggests Axonal Repair in Multiple Sclerosis Patients Treated with COPAXONE® Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
02 Jan 12 Teva Announces Management Succession Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
22 Dec 11 Dr. Rob Koremans to succeed Dr. Gerard van Odijk as President and CEO of Teva Europe Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
21 Dec 11 Teva Provides 2012 Non-GAAP Financial Outlook; 2012 Non-GAAP Diluted EPS of $5.48 to $5.68 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
21 Dec 11 Teva Announces $3 billion Share Repurchase Program Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
14 Dec 11 Teva to Host 2012 Business Outlook Conference Call Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
05 Dec 11 Teva to Present at the NASDAQ OMX 27th Investor Program Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.